09.23.14
Eisai Ltd. has opened its new Canadian headquarters in Mississauga. Eisai Ltd. was established in April 2010 as the Canadian subsidiary of Eisai Inc., the U.S. pharmaceutical operating company of Eisai Co., Ltd. Eisai Ltd. aims to meet diverse healthcare needs, with a focus on providing treatments, whenever possible, that address significant unmet medical needs.
"Our new office represents a commitment to growing our business and increasing Eisai's presence here in Canada," said Oliver Technow, president and general manager, Eisai Ltd. "Eisai selected Mississauga for its Canadian headquarters due to its central location within the GTA, the largest economic cluster in Canada and a region well-known for its diverse and highly educated talent pool."
"Over the past four years we have had tremendous success. We see potential for more opportunities to grow our team and to continue with our mission of putting patients first by providing medicines that help improve the lives of patients and their families," said Mr. Technow. "It is an exciting time for the organization and we look forward to continuing our success in Canada."
"Our new office represents a commitment to growing our business and increasing Eisai's presence here in Canada," said Oliver Technow, president and general manager, Eisai Ltd. "Eisai selected Mississauga for its Canadian headquarters due to its central location within the GTA, the largest economic cluster in Canada and a region well-known for its diverse and highly educated talent pool."
"Over the past four years we have had tremendous success. We see potential for more opportunities to grow our team and to continue with our mission of putting patients first by providing medicines that help improve the lives of patients and their families," said Mr. Technow. "It is an exciting time for the organization and we look forward to continuing our success in Canada."